EIF4E and glioblastoma: Ribavirin, an anti-viral drug that disrupts the interaction between eIF4E and the 5’ UTR end of mRNA (Figure 2), inhibits GBM cell growth and migration, and increases radio-/chemo-therapy efficacy in vivo [33,34].